Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Markus, Rey"'
Autor:
Emmanuel A. Meyer, Päivi Äänismaa, Eric A. Ertel, Eva Hühn, Daniel S. Strasser, Markus Rey, Mark J. Murphy, Marianne M. Martinic, Laetitia Pouzol, Sylvie Froidevaux, Marcel P. Keller, Eva Caroff
Publikováno v:
Journal of Medicinal Chemistry. 66:4179-4196
Publikováno v:
The Monetization of Technical Data ISBN: 9783662665084
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::729c5a890e8a09d60d88ddc767ae212d
https://doi.org/10.1007/978-3-662-66509-1_6
https://doi.org/10.1007/978-3-662-66509-1_6
Autor:
Olivier Bezençon, Thomas Pfeifer, Johannes Mosbacher, Isabelle Reymond, Eric A. Ertel, Ruben de Kanter, Bruno Capeleto, Elvire Fournier, Markus Rey, Luca Moccia, Michael Toeroek-Schafroth, René Roscher, Richard Moon, John Gatfield, Melanie Kessler, Romain Siegrist, Bibia Heidmann, Davide Pozzi, Simon Stamm, Luboš Remeň, Sylvia Richard, Lloyd Simons, Rick Gaston, Dennis Downing, Corinna Grisostomi, Catherine Roch, Benno Schindelholz
Publikováno v:
CHIMIA, Vol 71, Iss 10 (2017)
We describe the discovery and optimization of new, brain-penetrant T-type calcium channel blockers. We present optimized compounds with excellent efficacy in a rodent model of generalized absence-like epilepsy. Along the fine optimization of a chemic
Externí odkaz:
https://doaj.org/article/77760779eafd425e854518b6109e1f36
Autor:
Martine Baumann, Laurence Panicot-Dubois, Markus Rey, Sébastien Roux, Markus A. Riederer, Lydie Crescence, Christophe Dubois, Markus Kramberg
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, 2021, 10 (22), pp.5349. ⟨10.3390/jcm10225349⟩
Journal of Clinical Medicine, Vol 10, Iss 5349, p 5349 (2021)
Volume 10
Issue 22
Journal of Clinical Medicine, 2021, 10 (22), pp.5349. ⟨10.3390/jcm10225349⟩
Journal of Clinical Medicine, Vol 10, Iss 5349, p 5349 (2021)
Volume 10
Issue 22
Selatogrel, a potent and reversible antagonist of the P2Y12 receptor, inhibited FeCl3-induced thrombosis in rats. Here, we report the anti-thrombotic effect of selatogrel after subcutaneous applications in guinea pigs and mice. Selatogrel inhibited p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d96b3b0eea1541cef6fdf1ba86b3761
https://amu.hal.science/hal-03653449
https://amu.hal.science/hal-03653449
Autor:
Ulrich Mentzel, Markus Kramberg, Marc Iglarz, Enrico Vezzali, Frederic Trensz, Céline Bortolamiol, Daniel Wanner, Stephane Delahaye, Hakim Hadana, Daniel S. Strasser, Patrick Hess, Markus Rey, Joël Ménard, Martine Clozel
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 368:462-473
The endothelin (ET) system has emerged as a novel target for hypertension treatment where a medical need persists despite availability of several pharmacological classes, including renin angiotensin system (RAS) blockers. ET receptor antagonism has d
Publikováno v:
Monetarisierung von technischen Daten ISBN: 9783662629147
Unternehmen konnen in der heutigen Zeit mithilfe von fortgeschrittenen Formen der Datenanalyse Erkenntnisse erzielen, die sich unmittelbar in Wettbewerbsvorteile umsetzen lassen. Ermoglicht wird dies insbesondere durch eine exponentiell zunehmende Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8914373ff81a2ba39c3f3b28849efca6
https://doi.org/10.1007/978-3-662-62915-4_6
https://doi.org/10.1007/978-3-662-62915-4_6
Autor:
Markus Rey, Patrick Hess, Martine Clozel, Stéphane Delahaye, John Gatfield, Oliver Nayler, Beat Steiner
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74285 (2013)
Ponesimod, a selective S1P1 receptor modulator, reduces the blood lymphocyte count in all tested species by preventing egress of T and B cells from thymus and peripheral lymphoid organs. In addition, ponesimod transiently affects heart rate and atrio
Externí odkaz:
https://doaj.org/article/d79ad88e62a94ce89ceedd137f337bd6
Autor:
Christopher Kohl, Markus Rey, Ruben de Kanter, Cyrille Lescop, Maxime Boucher, Magdalena Birker-Robaczewska, Oliver Nayler, Martin Bolli, Sylvie Poirey, Beat Steiner
Publikováno v:
Molecular Pharmacology. 93:109-118
S1P1 (sphingosine-1-phosphate receptor 1) agonists prevent lymphocyte egress from secondary lymphoid organs and cause a reduction in the number of circulating blood lymphocytes. We hypothesized that S1P1 receptor modulators with pathway-selective sig
Autor:
Melanie Kessler, Eric A. Ertel, John Gatfield, Rick D Gaston, Corinna Grisostomi, Thomas Pfeifer, Lubos Remen, Lloyd Simons, Olivier Bezencon, Johannes Mosbacher, Catherine Roch, Richard Moon, Dennis Michael Downing, Markus Rey
Publikováno v:
Journal of Medicinal Chemistry. 59:8398-8411
A series of dihydropyrazole derivatives was developed as potent, selective, and brain-penetrating T-type calcium channel blockers. An optimized derivative, compound 6c, was advanced to in vivo studies, where it demonstrated efficacy in the WAG/Rij ra
Autor:
Thomas Weller, Martin Bolli, Claus Müller, Ruben de Kanter, Markus Rey, Magdalena Birker, Patrick Sieber, Cyrille Lescop, Christopher Kohl, Boris Mathys, Beat Steiner, Patrick Hess, Oliver Nayler
Publikováno v:
European Journal of Medicinal Chemistry. 116:222-238
In a previous communication we reported on the discovery of alkylamino pyridine derivatives (e.g. 1) as a new class of potent, selective and efficacious S1P1 receptor (S1PR1) agonists. However, more detailed profiling revealed that this compound clas